158 related articles for article (PubMed ID: 20669338)
1. Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy.
Terhorst L; Blair-Belansky H; Moore PJ; Bender C
Psychooncology; 2011 Sep; 20(9):961-8. PubMed ID: 20669338
[TBL] [Abstract][Full Text] [Related]
2. The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.
Stanton AL; Bernaards CA; Ganz PA
J Natl Cancer Inst; 2005 Mar; 97(6):448-56. PubMed ID: 15770009
[TBL] [Abstract][Full Text] [Related]
3. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.
Fallowfield LJ; Leaity SK; Howell A; Benson S; Cella D
Breast Cancer Res Treat; 1999 May; 55(2):189-99. PubMed ID: 10481946
[TBL] [Abstract][Full Text] [Related]
4. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Jakesz R; Greil R; Gnant M; Schmid M; Kwasny W; Kubista E; Mlineritsch B; Tausch C; Stierer M; Hofbauer F; Renner K; Dadak C; Rücklinger E; Samonigg H;
J Natl Cancer Inst; 2007 Dec; 99(24):1845-53. PubMed ID: 18073378
[TBL] [Abstract][Full Text] [Related]
5. Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.
Cella D; Land SR; Chang CH; Day R; Costantino JP; Wolmark N; Ganz PA
Breast Cancer Res Treat; 2008 Jun; 109(3):515-26. PubMed ID: 17851765
[TBL] [Abstract][Full Text] [Related]
6. Patterns of change in cognitive function with anastrozole therapy.
Bender CM; Merriman JD; Gentry AL; Ahrendt GM; Berga SL; Brufsky AM; Casillo FE; Dailey MM; Erickson KI; Kratofil FM; McAuliffe PF; Rosenzweig MQ; Ryan CM; Sereika SM
Cancer; 2015 Aug; 121(15):2627-36. PubMed ID: 25906766
[TBL] [Abstract][Full Text] [Related]
7. Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.
Bell MJ; Terhorst L; Bender CM
J Nurs Meas; 2013; 21(2):320-34. PubMed ID: 24053059
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
[TBL] [Abstract][Full Text] [Related]
9. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Carlson RW; Henderson IC
Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
[TBL] [Abstract][Full Text] [Related]
10. Psychometric Evaluation of the Chinese Breast Cancer Prevention Trial Symptom Scale.
Tsai CF; Tsai PS; Liu CL; Lin YK; Ling YL; Tseng IJ; Liao YM
Cancer Nurs; 2018; 41(4):E18-E30. PubMed ID: 28481776
[TBL] [Abstract][Full Text] [Related]
11. 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.
Buzdar AU;
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):399-403. PubMed ID: 14623537
[TBL] [Abstract][Full Text] [Related]
12. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
13. Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
Smith I; Yardley D; Burris H; De Boer R; Amadori D; McIntyre K; Ejlertsen B; Gnant M; Jonat W; Pritchard KI; Dowsett M; Hart L; Poggio S; Comarella L; Salomon H; Wamil B; O'Shaughnessy J
J Clin Oncol; 2017 Apr; 35(10):1041-1048. PubMed ID: 28113032
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Ganz PA; Cecchini RS; Julian TB; Margolese RG; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):857-65. PubMed ID: 26686960
[TBL] [Abstract][Full Text] [Related]
15. Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
Doggrell SA
Expert Opin Pharmacother; 2008 Jun; 9(9):1619-22. PubMed ID: 18518790
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.
Ohsumi S; Shimozuma K; Ohashi Y; Shinji M; Hozumi Y; Mukai H; Takatsuka Y; Aihara T
Breast Cancer Res Treat; 2011 May; 127(1):143-52. PubMed ID: 21347648
[TBL] [Abstract][Full Text] [Related]
17. Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
Bell R; Lewis J
Curr Med Res Opin; 2007 May; 23(5):1045-51. PubMed ID: 17519070
[TBL] [Abstract][Full Text] [Related]
18. The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.
Nugent BD; Sereika SM; Rosenzweig M; McCue M; Merriman JD; Bender CM
Support Care Cancer; 2016 Aug; 24(8):3401-9. PubMed ID: 26984246
[TBL] [Abstract][Full Text] [Related]
19. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
[TBL] [Abstract][Full Text] [Related]
20. Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer.
Sanford M; Plosker GL
Drugs; 2008; 68(9):1319-40. PubMed ID: 18547136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
